Searchable abstracts of presentations at key conferences in endocrinology

ea0031p337 | Steroids | SFEBES2013

Osteoporosis prophylaxis in medical patients taking corticosteroids

Carter Thomas , Simons Angeline , Nutt James , Smith Beng , Raja Maduri

Background: Oral corticosteroids are a known risk factor for developing osteoporosis and subsequent fracture at higher bone mineral density than post menopausal osteoporosis. Bone loss is thought to be most pronounced in the first 12 weeks of steroid use, and existing guidelines recommend a fracture risk assessment and appropriate osteoporosis prophylaxis with calcium and vitamin D supplements and bisphosphonates. There is also a recognized role for FRAX scoring to help strati...

ea0086oc6.4 | Thyroid | SFEBES2022

Towards an automated app-based dose prescription of carbimazole for hyperthyroidism patients

Reich Thilo , Bakirov Rashid , Budka Dominika , Kelly Derek , Smith James , Richardson Tristan , Budka Marcin

University Hospitals Dorset (UHD) has over 1,000 thyroid patient contacts annually. These are primarily patients with autoimmune hyperthyroidism and are treated by titration of Carbimazole. Dose adjustments are made by a healthcare professional (HCP) based on the results of thyroid function tests. Once the test results are available, the HCP decides on a prescription dose and communicates this to the patient, which is time-consuming and introduces delays. This project aims to ...

ea0087p12 | Poster Presentations | UKINETS2022

SIRT: adrenocortical carcinoma and liver metastases

Baxendale-Smith Leo , El-Shakankery Karim , Wall Lucy , Gordon-Smith James

Introduction: Selective internal radiation therapy (SIRT) is a novel intervention used to treat both primary and metastatic malignant liver lesions. Adrenocortical carcinoma (ACC) is a rare cancer with limited treatment options; evidence for SIRT use in ACC liver metastases is limited to case reports only. In this case we report prolonged and successful disease control using recurrent SIRT in a gentleman with liver-limited ACC.Case study: A 49-year-old g...

ea0021p287 | Pituitary | SFEBES2009

Patients with pituitary disease are at risk of under-replacement with levothyroxine

Koulouri Olympia , Auldin Mohammed A , Agarwal Ravi , Kieffer Veronica , Robertson Carole , Smith James Falconer , Levy Miles J , Howlett Trevor A

Introduction: Achieving optimal levothyroxine replacement is more difficult in TSH deficiency compared to primary hypothyroidism because of the inability to be guided by TSH. A combination of clinical symptoms and free thyroxine levels (fT4) are typically used to monitor replacement. We reviewed adequacy of levothyroxine replacement in our patients with pituitary disease, and compared with fT4 levels in patients with primary thyroid disease.<p class="...